Neurocrine Biosciences Inc (NBIX)

Finanzdaten der Neurocrine Biosciences Inc-Aktie (NBIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	17.07%1,122.70	959.00	814.50	805.50	794.90
	16.69%366.30	439.70	318.50	-	-
Selling, General, and Administrative	16.69%366.30	439.70	318.50	-	-
Costs And Expenses	1.99%791.40	807.50	621.10	594.60	555.90
Operating Income/Loss	118.68%331.30	151.50	193.40	210.90	239.00
Nonoperating Income/Loss	544.86%-47.60	10.70	53.40	28.50	52.80
Income/Loss From Continuing Operations Before Tax	74.91%283.70	162.20	246.80	239.40	291.80
Income Tax Expense/Benefit	333.71%77.20	17.80	48.90	85.70	82.30
	43.01%206.50	144.40	197.90	153.70	209.50
Attributable To Parent	43.01%206.50	144.40	197.90	153.70	209.50
Available To Common Stockholders, Basic	43.01%206.50	144.40	197.90	153.70	209.50
Basic Average Shares	0.59%101.60	101.00	100.50	0.20	99.40
Diluted Average Shares	0.96%105.20	104.20	103.40	0.50	102.50
Basic Earnings Per Share	41.96%2.03	1.43	1.97	1.54	2.11
Diluted Earnings Per Share	41.01%1.96	1.39	1.91	1.48	2.04